BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4403218)

  • 21. [Longitudinal studies on the metabolite pattern of perazine and related phenothiazines in human and animal].
    Breyer U
    Arzneimittelforschung; 1974 Jul; 24(7):989-90. PubMed ID: 4152695
    [No Abstract]   [Full Text] [Related]  

  • 22. Tissue metabolites of trifluoperazine, fluphenazine, prochlorperazine, and perphenazine in the rat: indentification and synthesis.
    Breyer U; Prox A; Bertele R; Gaertner HJ
    J Pharm Sci; 1974 Dec; 63(12):1842-8. PubMed ID: 4449013
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of a urinary metabolite of perazine as a piperazine-2,5-dione derivative.
    Krauss D; Otting W; Breyer U
    J Pharm Pharmacol; 1969 Dec; 21(12):808-13. PubMed ID: 4391052
    [No Abstract]   [Full Text] [Related]  

  • 24. [The metabolism of psychotropic drugs (phenothiazine and iminodibenzyl derivatives)].
    Abakumov VM; Vikhliaev IuI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(3):444-52. PubMed ID: 4911659
    [No Abstract]   [Full Text] [Related]  

  • 25. The metabolic alteration of drugs.
    Schreiber EC
    Annu Rev Pharmacol; 1970; 10():77-98. PubMed ID: 4392814
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological properties of a potential tranquilising agent mesylphenacyrazine. I. Interaction with drugs influencing the nervous system.
    Metys J; Metysová J
    Act Nerv Super (Praha); 1974 Aug; 16(3):161. PubMed ID: 4153867
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review.
    Otręba M; Kośmider L
    J Appl Toxicol; 2021 Jan; 41(1):82-94. PubMed ID: 32852120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reports from the general practitioner research group. Antihistamine and phenothiazine compared in vertigo.
    Practitioner; 1973 Aug; 211(262):224-7. PubMed ID: 4147012
    [No Abstract]   [Full Text] [Related]  

  • 29. Excretion and metabolism of flunarizine in rats and dogs.
    Meuldermans W; Hendrickx J; Hurkmans R; Swysen E; Woestenborghs R; Lauwers W; Heykants J
    Arzneimittelforschung; 1983; 33(8):1142-51. PubMed ID: 6685491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prothidryl--combination of antihistaminic bromadryl and thymoleptic prothiaden. Pharmacological study.
    Votava Z; Metys J; Dlabac A
    Act Nerv Super (Praha); 1972; 14(2):120-1. PubMed ID: 4402690
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism, distribution and excretion of flupenthixol.
    Jorgensen A; Hansen V; Larsen UD; Khan AR
    Acta Pharmacol Toxicol (Copenh); 1969; 27(4):301-13. PubMed ID: 5394747
    [No Abstract]   [Full Text] [Related]  

  • 32. EPR studies on the mechanism of biotransformation of tricyclic neuroleptics and antidepressants.
    Fenner H
    Adv Biochem Psychopharmacol; 1974; 9(0):5-13. PubMed ID: 4365284
    [No Abstract]   [Full Text] [Related]  

  • 33. [Arousal inhibiting and catalepsy in neuroleptic drugs].
    Stille G
    Arzneimittelforschung; 1966 Feb; 16(2):255-6. PubMed ID: 6013811
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neurotropic properties of fluphenazine].
    Liubimov BI; Raevskiĭ KS; Ostrovskaia RU; Barkov NK; Krolevets GN
    Farmakol Toksikol; 1971; 34(3):287-90. PubMed ID: 5106035
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathways of medazepam metabolism in the dog and rat.
    Schwartz MA; Kolis SJ
    J Pharmacol Exp Ther; 1972 Jan; 180(1):180-8. PubMed ID: 5010413
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on an unusual N-dealkylation reaction. II. Characteristics of the enzyme system and a proposed pathway for the reaction.
    Kamm JJ; Szuna A
    J Pharmacol Exp Ther; 1973 Mar; 184(3):729-38. PubMed ID: 4405709
    [No Abstract]   [Full Text] [Related]  

  • 37. Anabolic activity of buclizine on rats.
    Kulkarni SD; Joglekar GV; Balwani JH
    Eur J Pharmacol; 1972 Feb; 17(2):312-4. PubMed ID: 4402100
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental teratogenicity of structurally similar compounds with or without piperazine-ring: a preliminary report.
    Druga A; Nyitray M; Szaszovszky E
    Pol J Pharmacol Pharm; 1980; 32(2):199-204. PubMed ID: 6109278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cumulating metabolite derived from a piperazine-substituted phenothiazine drug.
    Breyer U; Krauss D; Jochims CJ
    Experientia; 1972 Mar; 28(3):312-3. PubMed ID: 5026447
    [No Abstract]   [Full Text] [Related]  

  • 40. Noroxyclothepin decanoate (VUFB-9976) long-acting neuroleptic drug.
    Kazdová E; Dlabac A
    Act Nerv Super (Praha); 1973 May; 15(2):81-2. PubMed ID: 4752673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.